¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"vitamin D resistant rickets"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vitamin D milk
    ºñŸ¹ÎD÷°¡¿ìÀ¯
  • vitamin deficiency
    ºñŸ¹Î°áÇÌ(Áõ)
  • vitamin E
    ºñŸ¹ÎE
  • vitamin K
    ºñŸ¹ÎK
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hepatic rickets
    °£¼º±¸·çº´(¡­ תܻ).
  • hypophosphatemic rickets
    ÀúÀλê(¿°)Ç÷¼º ±¸·çº´(¡­àõ ׬ܻ).
  • infantile rickets
    ¿µ¾Æ±¸·çº´(?ä® ×§Ü»).
  • late rickets
    ¸¸¹ß±¸·çº´.
  • late rickets
    ¸¸¹ß ±¸·çº´.
  • refractory rickets
    ³­Ä¡±¸·çº´(Ññö½ ׬ܻ).
  • refractory rickets
    ³­Ä¡±¸·çº´(Ññö½ ׬ܻ)
  • renal rickets
    ½Å¼º±¸·çº´
  • renal rickets
    ½Å¼º ±¸·çº´(ãìàõ ץܻ).
  • renal rickets
    ½Å¼º ±¸·çº´(¡­±¸·çÜ»)
  • rickets
    ±¸·çº´(±¸ ׬ܻ).
  • rickets
    ±¸·çº´( ׬ܻ).
  • rickets
    ±¸·çº´(±¸·çÜ»)
  • antihemorrhagic vitamin
    Ç×ÃâÇ÷¼º ºñŸ¹Î.
  • antipellagra vitamin
    Çׯç¶ó±×¶óºñŸ¹Î.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vitamin A1
    ºñŸ¹Î A1
  • vitamin A2
    ºñŸ¹Î A2
  • vitamin A1 acid
    ºñŸ¹Î A1 »ê(ß«)
  • vitamin A1 alcohol
    ºñŸ¹Î A1 ¾ËÄÚȦ
  • vitamin A1 aldehyde
    ºñŸ¹Î A1 ¾Ëµ¥ÇÏÀ̵å
  • vitamin B
    ºñŸ¹Î B
  • vitamin B1
    ºñŸ¹Î B1
  • vitamin B2
    ºñŸ¹Î B2
  • vitamin B3
    ºñŸ¹Î B3
  • vitamin B5
    ºñŸ¹Î B5
  • vitamin B6
    ºñŸ¹Î B6
  • vitamin B12
    ºñŸ¹Î B12
  • vitamin B complex
    ºñŸ¹Î B º¹ÇÕü (ÜÜùêô÷)
  • Vitamin B group
    ºñŸ¹Î B ±º(ÏØ)
  • vitamin C
    ºñŸ¹Î C
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SR sarcoplasmic reticulum; saturation recovery; scanning radiometer; screen; secretion rate; sedimentat...
FHR familial hypophosphatemic rickets; fetal heart rate
HHRH hereditary hypophosphatemic rickets with hypercalciuria; hypothalamic hypophysiotropic releasing hor...
HR heart rate; hemorrhagic retinopathy; high resolution; higher rate; histamine receptor; hormonal resp...
PDDR pseudovitamin D-dependent rickets
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
VD3 1,25-dihydroxy-Vitamin D3
VDR 1,25-dihydroxy-vitamin D3 receptor
VDR D/vitamin D receptor
hVDR Human vitamin D receptor
PIVKA-II Protein induced by vitamin K absence or antagonist II
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • vitamin B 21
    ºñŸ¹ÎB 21
  • vitamin B complex
    ºñŸ¹ÎB º¹ÇÕü
  • vitamin B12
    ºñŸ¹Î B12
    ½Ã¾Æ³ëÄڹ߶ó¹Î. Ç׺óÇ÷ ÀÎÀڷμ­ Àû»ö °áÁ¤. 4°³ÀÇ ÇÇ·Ñ ÇÙÀÇ 3°³ÀÇ Åº¼Ò ¿øÀÚ¿Í 6°³ÀÇ °ø¿ª ÀÌÁß °áÇÕÀ» Áö´Ñ ȯ»ó ±¸Á¶¸¦ ÀÌ·ç¸ç ÄÚ¹ßÆ®¸¦ Áö´Ñ´Ù. ½Ã¾È±â°¡ ÄÚ¹ßÆ®¿¡ ¹èÀ§°áÇÕÇØ ÀÖ´Ù. ºñŸ¹Î B12´Â ¼ö¿ë¼ºÀÌ¸ç ¾ËÄڿÿ¡ ¿ëÇØÇÏÁö¸¸ ¾Æ¼¼Åæ, ¿¡Å׸£¿¡´Â ³ìÁö ¾Ê´Â´Ù. »ê¿¡ ¾ÈÁ¤, ¾ËÄ®¸®¿¡´Â ºÒ¾ÈÁ¤ÇÏ´Ù. Co¿øÀÚ¿¡ °áÇÕÇÑ ½Ã¾È±â ´ë½Å¿¡ OH±â¶ó¸é ÇÏÀ̵å·Î¿Á½Ã Äڹ߶ó¹Î, CH3±â¶ó¸é ¸ÞÆ¿ Äڹ߶ó¹ÎÀ̶ó°í ÇÑ´Ù. ½Ã¾Æ³ë Äڹ߶ó¹Î ¼ö¿ë¾×Àº 278nm, 361nm, 548nm¿¡¼­ ÃÖ´ëÇÑ Èí¼öµÈ´Ù. ÀÌ ºñŸ¹ÎÀº Á¶Ç÷ ±â±¸¿¡ Áß¿äÇϸç, RNA¿¡¼­ DNAÀÇ Çü¼º ¹ÝÀÀ¿¡ °ü¿©ÇÑ´Ù°í »ý°¢µÈ´Ù. ½Ä»çÁßÀÇ ºñŸ¹Î B12´Â ¼ÒÀå Á¾¸»ºÎ¿¡¼­ Ä®½·, À§º®¿¡¼­ »ý»êµÇ´Â ³»ÀÎÀÚ ¹«ÄڴܹéÀÇ Á¸Àç ¾Æ·¡ Èí¼öµÈ´Ù. Ç÷û ¹Ý°¨±â´Â ¾à 1ÁÖÀÏÀÌ´Ù.
  • vitamin B12-intrinsic factor
    ºñŸ¹Î B12-³»Àμº ÀÎÀÚ
  • vitamin B2 deficiency
    ºñŸ¹Î B2 °áÇÌÁõ
  • vitamin C
    ºñŸ¹Î C
    ¾Æ½ºÄݺó»ê. Ç×±«Ç÷Áõ ÀÛ¿ëÀ» ÇÑ´Ù. ¿­¿¡ ¾àÇÏ°í °­·ÂÇÑ È¯¿ø ÀÛ¿ëÀÌ ÀÖ¾î, ¿©·¯ È¿¼ÒÀÇ ÀÛ¿ë ¹ßÇö¿¡ ÀÖ¾î Àû´çÇÑ »êȭȯ¿ø »óÅÂÀÇ À¯Áö¿¡ µµ¿òÀÌ µÇ¸ç, ¼ö¼Ò¿î¹Ýü·Î¼­ ÀÛ¿ëÇϰí ÀÖ´Ù. »êÈ­´Â ºû, ¾ËÄ®¸®, ö, ±¸¸®¿¡ ÀÇÇÏ¿© ÃËÁøµÈ´Ù. ½ºÅ×·ÎÀÌµå »ýÇÕ¼º ¶§ÀÇ ¼ö»êÈ­¿¡µµ ¾Æ½ºÄÚ¸£ºó »êÀÌ °ü¿©ÇÑ´Ù.
  • vitamin compound
    ºñŸ¹Î º¹ÇÕÁ¦
    ºñŸ¹ÎÀ» ÁÖ¼ººÐÀ¸·Î ÇÏ´Â ¿µ¾çÁ¦·Î¼­ ºñŸ¹Î °áÇÌÁõÀÇ Ä¡·á¿Í ¿¹¹æ¿¡ »ç¿ëµÇ´Â ÀǾàǰ. ÇöÀç ºñŸ¹Î B2¸¦ Á¦¿ÜÇÑ ´ëºÎºÐÀÇ ºñŸ¹ÎµéÀº ÇÕ¼ºÇÒ ¼ö ÀÖ°í È­Çлê¾÷¿¡ ÀÇÇØ ´Ù·®À¸·Î Á¦Á¶°¡ °¡´ÉÇϹǷΠ´ëºÎºÐÀÇ ºñŸ¹ÎÁ¦´Â ÇÕ¼ºÇ°À¸·Î ¸¸µé¾îÁø´Ù. ´ÜÀÏ Á¦Á¦ Áß¿¡ ÇÑ Á¾·ùÀÇ ºñŸ¹ÎÀ» Æ÷ÇÔÇϵµ·Ï ¸¸µç ´ÜÀÏ ºñŸ¹ÎÁ¦, Áö¿ë¼º ÈæÀº ¼ö¿ë¼º ºñŸ¹Î ¸î Á¾·ù¸¸À» º¹ÇÕ½ÃÄÑ ¸¸µç º¹ÇÕ ºñŸ¹ÎÁ¦, °ÅÀÇ ¸ðµç ºñŸ¹ÎÀ» Æ÷ÇÔÇϵµ·Ï ¸¸µç Á¾ÇÕ ºñŸ¹ÎÁ¦°¡ ÀÖ¾î ¿ëµµ¿¡ µû¶ó »ç¿ëµÈ´Ù. ºñŸ¹ÎÁ¦´Â Áúº´, ¾Ë·¹¸£±â, ½Ä»çÀÇ Á¦ÇÑ µî ¾î¶² ÀÌÀ¯¿¡¼­ ÀûÀýÇÑ ½Ä»ç¸¦ ÇÏÁö ¸øÇÏ´Â »ç¶÷¿¡°Ô´Â ¸Å¿ì À¯¿ëÇϳª Á¤±Ô½Ä»ç¸¦ ÇÏ´Â °Ç°­ÇÑ »ç¶÷ÀÌ ºñŸ¹ÎÀ» ´õ º¸Ãæ¼·ÃëÇϱâ À§ÇÏ¿© »ç¿ëÇÏ´Â °ÍÀº ³¶ºñÀ̰ųª ÇØ°¡ µÇ´Â °æ¿ìµµ ÀÖÀ¸¹Ç·Î »ï°¡¾ß ÇÑ´Ù. 5°¡Áö ±âÃʽÄǰ±º¿¡ ±âº»À» µÐ ±ÕÇü½Ä»ç´Â ¸öÀÌ ÇÊ¿ä·Î ÇÏ´Â ¸ðµç ºñŸ¹ÎÀ» °ø±ÞÇϱ⿡ ÃæºÐÇϸç, Çʿ䷮ ÀÌ»óÀÇ ºñŸ¹ÎÀÌ °Ç°­¿¡ ÇØ·Ó±â ¶§¹®ÀÌ´Ù. Á¤±Ô½Ä»ç¸¦ ÅëÇÑ ºñŸ¹ÎÀÇ ¼·Ãë´Â °áÄÚ °úÀ× µ¶¼º¼öÁرîÁö °¡Áö ¾ÊÁö¸¸, ³óÃàµÈ ºñŸ¹ÎÁ¦¸¦ °è¼Ó ¸ÔÀ¸¸é °úÀ× µ¶¼º ¼öÁرîÁö À̸£°Ô µÈ´Ù. ½Ä»ç¸¦ ÅëÇÏ¿© °Ç°­À¯Áö¿Í Áúº´¿¹¹æ¿¡ ÇÊ¿äÇÑ ¸ðµç ºñŸ¹ÎÀ» ¼·ÃëÇØ¾ß ÇÑ´Ù.
  • vitamin D
    ºñŸ¹ÎD
    ºñŸ¹ÎÀÇ ÇѰ¡Áö. Ç÷¾× ¼ÓÀÇ Ä®½·À» Á¶ÀýÇÏ¸ç °áÇÌµÇ¸é ±¸·çº´ÀÌ µÊ. °£À¯, ´Þ°¿ ³ë¸¥ÀÚ µûÀ§¿¡ µé¾î ÀÖÀ½.
  • vitamin D deficiency
    ºñŸ¹Î D °áÇÌ, ºñŸ¹Î D °áÇÌÁõ
    ±¸·çº´-°ñ¿¬È­ÁõÀ¸·Î µî»À³ª °¡½¿»À µûÀ§°¡ ±Á´Â º´. °ö»çº´.
  • vitamin D dependency
    ºñŸ¹Î D ÀÇÁ¸¼º
  • vitamin D milk
    ºñŸ¹ÎD ¿ìÀ¯
  • vitamin deficiency
    ºñŸ¹Î °áÇÌ, ºñŸ¹Î °áÇÌÁõ
    ¸é Á¾·ùÀÇ ½ÄǰÀ» ¼¯Àº º¸ÅëÀÇ ½Ä»ç¸¦ º¸Åë Á¶¸®¹ý¿¡ µû¶ó ¸ÔÀ» °æ¿ì´Â ºñŸ¹Î °áÇÌÁõÀÌ ³ªÅ¸³ªÁö ¾Ê´Â´Ù. ±×·¯³ª ¿¹¿Ü·Î½á ºñŸ¹Î D°áÇÌÁõÀº ÀÚÁÖ ³ªÅ¸³­´Ù. ½Äǰ Áß¿¡´Â ¿©·¯ Á¾·ùÀÇ ºñŸ¹ÎÀÌ °øÁ¸Çϰí Àֱ⠶§¹®¿¡ 1 Á¾·ù¸¸ÀÇ ºñŸ¹Î °áÇÌÁõº¸´Ùµµ ¿©·¯ Á¾·ùÀÇ ºñŸ¹Î °áÇÌÁõÀÌ ¸¹´Ù. ¼ÒÈ­±â Áúȯ¿¡ ¼ö¹ÝµÇ´Â Èí¼öÀå¾Ö, °¢Á¾ ¾àÀçÀÇ º¹¿ë¿¡ ÀÇÇÑ Àå³» ¼¼±ÕÃþÀÇ º¯È­, ü³»¿¡¼­ÀÇ ºñŸ¹Î Ȱ¼ºÈ­ÀÇ ÀúÇØ, »ý¸®Àû º¯È­¿¡ ´ëÀÀÇÑ ¿ä±¸·®ÀÇ Áõ°¡, °¨¿° µî¿¡ ÀÇÇØ °áÇÌÁõÀÌ ¹ß°ßµÇ´Â °æ¿ì°¡ ÀÖ´Ù. ±×·¯³ª ¾àÇÑ Á¤µµÀÇ °áÇÌÀÎ °æ¿ì¿¡´Â ÀüÇüÀû Áõ»óÀº º¸ÀÌÁö ¾ÊÀ¸¸ç, ÀÌ ¶§ÀÇ Áõ»óÀ» ºñŸ¹Î °¨¼ÒÁõÀ̶ó°í ÇÑ´Ù.
  • vitamin deficiency symptom
    ºñŸ¹Î °áÇÌÁõ
    ºñŸ¹ÎÀÇ ºÎÁ·À¸·Î ÀϾ´Â »ý¸® ±â´É Àå¾Ö. ¾ß¸ÍÁõ, °¢±âº´ µûÀ§°¡ ÀÖ´Ù.
  • vitamin E
    ºñŸ¹ÎE
    ºñŸ¹ÎÀÇ ÇÑ °¡Áö. °áÇÌµÇ¸é ºÒÀÓ, À¯»ê µîÀ» ÀÏÀ¸Å´.
  • vitamin I deficiency
    ºñŸ¹Î °áÇÌ, ºñŸ¹Î °áÇÌÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
multiple drug resistant tuberculosis A strain of TB that does not respond to two or more standard anti-TB drugs. MDR-TB usually occurs when treatment is interrupted thus allowing mutations in the organism to occur that confer drug resistance.
(09 Oct 1997)
drug resistant Unresponsive to the desired effects of drugs or other therapy for example: irradiation cytotoxic agents or hormones. Drug resistance of cells within tumours is probably the major cause of treatment failure.
(16 Dec 1997)
tartrate-resistant acid phosphatase <biochemistry, enzyme> Acid phosphatase is present in bone, prostate, platelets, erythrocytes and spleen.
Osteoclasts contain an isoenzyme that is resistant to tartrate, whereas, the isoenzyme in the prostate is sensitive. Tartrate-resistant acid phosphatase is elevated in the serum of patients with primary hypoparathyroidism, Paget disease, vertebral osteoporosis, T-cell lymphoma and in women after oophorectomy. Oestrogen replacement in osteoporotic postmenopausal women is associated with a decrease in tartrate-resistant acid phosphatase of 70% over 3 to 6 months.
Acronym: TRAP
(16 Dec 1997)
tuberculosis, multidrug-resistant Tuberculosis resistant to chemotherapy with two or more antitubercular agents. The problem of resistance is particularly troublesome in tuberculosis as an opportunistic disease in HIV infection.
(12 Dec 1998)
ketosis-resistant diabetes Type II or adult onset diabetes mellitus, in which episodes of ketoacidosis rarely occur.
(05 Mar 2000)
antiberiberi vitamin A member of the water-soluble B vitamin group, necessary for energy production and carbohydrate metabolism. Deficiency is known as beriberi.
(27 Sep 1997)
antihemorrhagic vitamin <biochemistry> A fat soluble vitamin that plays an important role in blood clotting.
(27 Sep 1997)
antineuritic vitamin A member of the water-soluble B vitamin group, necessary for energy production and carbohydrate metabolism. Deficiency is known as beriberi.
(27 Sep 1997)
antiscorbutic vitamin <biochemistry> A requisite in the diet of man and guinea pigs. May act as a reducing agent in enzymic reactions, particularly those catalysed by hydroxylases.
Synonym: Vitamin C.
(18 Nov 1997)
antisterility vitamin <biochemistry> Functions as an antioxidant, binds oxygen free radicals that can cause tissue damage, may also play a protective role in the coronary arteries from the damaging effects of cholesterol.
(27 Sep 1997)
b-complex vitamin <biochemistry> A group of vitamins that includes: B1(thiamin), B2 riboflavin), B3 (niacin), B6(pyridoxine), B12 (cobalamin) and folate.
(24 Mar 1998)
vitamin <biochemistry> An essential low molecular weight organic compound required in trace amounts for normal growth and metabolic processes. They usually serve as components of coenzyme systems.
For humans Vitamin A, the B series, C, D1 and D2, E and K are required. Deficiencies of one or more vitamins in the nutrient supply result in deficiency diseases.
(11 Nov 1997)
vitamin A <biochemistry> Deficiency of this vitamin interferes with the production of rhodopsin in the eye resulting in night blindness and xerophthalmia.
(27 Sep 1997)
vitamin A1 Vitamin A1alcohol; 2,6,6-trimethyl-1-(9'-hydroxy-3',7'-dimethylnona-1',3',5',7'-tetraenyl)cyclohex-1-ene;a half-carotene bearing the b (or beta-ionone) form of the cyclic end group and a CH2OH at the C-15 position (numbering as in carotenoids) or 9'-position (numbering as a nonyl side chain on a cyclohexene ring); an intermediate in the vision cycle, it also plays a role in growth and differentiation.
See: dehydroretinol.
Synonym: vitamin A1 alcohol, vitamin A1.
Retinol dehydrogenase, an oxidoreductase catalyzing interconversion of retinal and NADH to retinol and NAD+.
(05 Mar 2000)
vitamin A1 acid <biochemistry> The aldehyde (retinal) has long been known to be involved in photoreception, but retinoic acid has other roles.
There are cytoplasmic retinoic acid binding proteins and retinoic acid response elements that regulate gene transcription. Retinoic acid is thought to be a morphogen in chick limb bud development and in early development of the chick that probably accounts for its potent teratogenic action.
Synonym: vitamin A.
(03 Jul 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á